WuXi AppTec (02269.HK) issued 4.055 million shares in accordance with the pre-emptive rights plan before the initial public offering.

The Zhtng Finance and Economics App news reports that WuXi Biologics (02269.HK) announced that the company issued a total of 4.055 million ordinary shares on November 10, 2025 to exercise stock options granted under the first public offering pre-emptive rights plan adopted by the company on January 5, 2016 (revised on August 10, 2016).